Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|October 14, 2017
Estrogen Metabolism in Abdominal Subcutaneous and Visceral Adipose Tissue in Postmenopausal WomenNatalia Hetemäki, Hanna Savolainen-Peltonen, Matti J Tikkanen, et al.
International Journal of Cardiology|September 5, 2013
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levelsMatti J Tikkanen, Rana Fayyad, Ole Faergeman, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL studyAnders G Olsson, Christina Lindahl, Ingar Holme, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|April 6, 2016
Dirty limit scattering behind the decreased anisotropy of doped YBa2Cu3O7-δ thin filmsM Malmivirta, H Palonen, S Inkinen, et al.
American Journal of Human Genetics|January 1, 1992
Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human geneA M Dunning, H H Renges, C F Xu, et al.
Human Biology|February 1, 1994
New data for AG haplotype frequencies in Caucasoid populations and selective neutrality of the AG polymorphismA Sanchez-Mazas, E Bütler-Brunner, L Excoffier, et al.
Human Genetics|July 1, 1989
Apolipoprotein B amino acid 3611 substitution from arginine to glutamine creates the Ag (h/i) epitope: the polymorphism is not associated with differences in serum cholesterol and apolipoprotein B levelsC F Xu, N Nanjee, M J Tikkanen, et al.
Atherosclerosis|March 31, 2009
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)Ingar Holme, Timo E Strandberg, Ole Faergeman, et al.
Annals of Medicine|January 23, 2009
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL)Ingar Holme, Nilo B Cater, Ole Faergeman, et al.
Journal of Immunological Methods|September 24, 1987
A monoclonal antibody (BIP 45) detects Ag(c,g) polymorphism of human apolipoprotein BP Duriez, R Butler, M J Tikkanen, et al.
Pageof 24